Nanolek is a Russian biopharmaceutical company, the sole founder of which is located in Cyprus. The average number of employees as of January 1, 2021 is 800 people. Russian pharmaceutical company Nanolek was founded in 2011 and it specializes in production of import-substituting drugs for prevention and treatment of socially significant diseases.